Raymond James Financial »

Springworks Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-06-30 $7.5k 159 46.99
2025-03-31 $6.2M 141k 44.13
2024-12-31 $11M 291k 36.13

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Springworks Therapeutics

DekaBank Deutsche Girozentrale
Advisor Group Holdings
Huntington National Bank

View all funds holding Springworks Therapeutics